Nordea Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-23,100
Closed -$854K 1040
2016
Q4
$854K Buy
23,100
+9,800
+74% +$350K ﹤0.01% 779
2016
Q3
$461K Buy
+13,300
New +$466K ﹤0.01% 833
2016
Q1
Sell
-6,618
Closed -$221K 964
2015
Q4
$221K Sell
6,618
-1,417
-18% -$44.1K ﹤0.01% 734
2015
Q3
$229K Buy
8,035
+3,057
+61% +$107K ﹤0.01% 692
2015
Q2
$202K Buy
4,978
+206
+4% +$9.25K ﹤0.01% 726
2015
Q1
$235K Sell
4,772
-46,162
-91% -$2.14M ﹤0.01% 708
2014
Q4
$2.32M Buy
+50,934
New +$2M 0.01% 349

Other funds holding AVNS

Nordea Investment Management's AVNS Position: Q1 2017 in Review

Nordea Investment Management sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 23,100 shares — an estimated $854K sold.

Nordea Investment Management first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $2.32M in Q4 2014. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Nordea Investment Management reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Nordea Investment Management sold 23,100 Avanos Medical shares in Q1 2017, an estimated $854K.
  • Nordea Investment Management first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
  • Nordea Investment Management's Avanos Medical position peaked at $2.32M in Q4 2014.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Nordea Investment Management's 13F filing for Q1 2017, filed 9 May 2017.